← FDA Drug Approvals (Drugs@FDA)
LANTRISUL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT · Approved 1978-08-24
Drug application
- FDA Application #
ANDA080123- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LANTRISUL
- Generic name
- Trisulfapyrimidines (Sulfadiazine
- Active ingredients
- TRISULFAPYRIMIDINES (SULFADIAZINE; SULFAMERAZINE; SULFAMETHAZINE)
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LANNETT
- First approval
- 1978-08-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown